| 51 |
17893044 | Doxorubicin generates a proapoptotic phenotype by phosphorylation of elongation factor 2. | 2007 Nov 1 |
4 |
| 52 |
17922852 | Low concentrations of doxorubicin sensitizes human solid cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-receptor (R) 2-mediated apoptosis by inducing TRAIL-R2 expression. | 2007 Dec |
2 |
| 53 |
18006836 | Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell death. | 2007 Nov 15 |
2 |
| 54 |
16327988 | Anticancer agents sensitize osteosarcoma cells to TNF-related apoptosis-inducing ligand downmodulating IAP family proteins. | 2006 Jan |
1 |
| 55 |
16428504 | Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death. | 2006 Jan 15 |
2 |
| 56 |
16619517 | C-jun N-terminal kinase activation is required for apoptotic cell death induced by TNF-related apoptosis-inducing ligand plus DNA-damaging agents in sarcoma cell lines. | 2006 Mar-Apr |
2 |
| 57 |
16923369 | [Role of caspase-8 and DR5 in TRAIL-induced apoptosis of neuroblastoma cells]. | 2006 Aug |
1 |
| 58 |
17047073 | Tumor necrosis factor-related apoptosis-inducing ligand is required for tumor necrosis factor alpha-mediated sensitization of human breast cancer cells to chemotherapy. | 2006 Oct 15 |
2 |
| 59 |
17106251 | Targeting the short form of cFLIP by RNA interference is sufficient to enhance TRAIL sensitivity in PC3 prostate carcinoma cells. | 2006 Dec |
2 |
| 60 |
15781649 | Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro. | 2005 Mar 15 |
1 |
| 61 |
15809718 | Expression of TNF-related apoptosis-inducing ligand in human hepatocellular carcinoma. | 2005 May |
1 |
| 62 |
15897917 | Subtoxic concentration of doxorubicin enhances TRAIL-induced apoptosis in human prostate cancer cell line LNCaP. | 2005 |
6 |
| 63 |
16098063 | Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL-R1 and TRAIL-R2 in primary and cultured lymphoma cells: induction of apoptosis and enhancement of doxorubicin- and bortezomib-induced cell death. | 2005 Aug |
1 |
| 64 |
15067350 | Sensitivity of fresh isolates of soft tissue sarcoma, osteosarcoma and giant cell tumour cells to Apo2L/TRAIL and doxorubicin. | 2004 May |
4 |
| 65 |
15110186 | TRAIL and chemotherapeutic drugs in cancer therapy. | 2004 |
1 |
| 66 |
15289869 | Doxorubicin potentiates TRAIL cytotoxicity and apoptosis and can overcome TRAIL-resistance in rhabdomyosarcoma cells. | 2004 Sep |
6 |
| 67 |
15329202 | [Tumor necrosis factor related apoptosis-inducing ligand induces apoptosis and sensitizes resistant hepatic cancer cells to chemotherapy]. | 2004 Aug |
2 |
| 68 |
12584736 | Enhancement of TRAIL/Apo2L-mediated apoptosis by adriamycin through inducing DR4 and DR5 in renal cell carcinoma cells. | 2003 Apr 20 |
2 |
| 69 |
12610517 | A mechanism of resistance to TRAIL/Apo2L-induced apoptosis of newly established glioma cell line and sensitisation to TRAIL by genotoxic agents. | 2003 Jan 27 |
1 |
| 70 |
12660816 | Chemotherapy enhances TNF-related apoptosis-inducing ligand DISC assembly in HT29 human colon cancer cells. | 2003 Mar 27 |
1 |
| 71 |
12763223 | Trail-induced apoptosis and interaction with cytotoxic agents in soft tissue sarcoma cell lines. | 2003 Jun |
9 |
| 72 |
12800232 | Synergistic antitumor effect of TRAIL and doxorubicin on colon cancer cell line SW480. | 2003 Jun |
5 |
| 73 |
12835727 | Ex vivo purging of leukemia cells using tumor-necrosis-factor-related apoptosis-inducing ligand in hematopoietic stem cell transplantation. | 2003 Jul |
11 |
| 74 |
12838325 | Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy. | 2003 Jul 7 |
2 |
| 75 |
12904602 | TRAIL/Apo2L ligands induce apoptosis in malignant rhabdoid tumor cell lines. | 2003 Nov |
4 |
| 76 |
12919886 | Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential. | 2003 Sep |
1 |
| 77 |
12926060 | Retrovirus-mediated transduction of TRAIL and chemotherapeutic agents co-operatively induce apoptotic cell death in both sarcoma and myeloma cells. | 2003 Jul-Aug |
2 |
| 78 |
12946317 | Combination of TRAIL gene therapy and chemotherapy enhances antitumor and antimetastasis effects in chemosensitive and chemoresistant breast cancers. | 2003 Sep |
2 |
| 79 |
14500373 | Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo. | 2003 Sep 1 |
4 |
| 80 |
14601052 | Selective and nonselective toxicity of TRAIL/Apo2L combined with chemotherapy in human bone tumour cells vs. normal human cells. | 2003 Dec 20 |
4 |
| 81 |
15033719 | Restoration of TRAIL-induced apoptosis in a caspase-8-deficient neuroblastoma cell line by stable re-expression of caspase-8. | 2003 Dec |
4 |
| 82 |
11803469 | TRAIL and inhibitors of apoptosis are opposing determinants for NF-kappaB-dependent, genotoxin-induced apoptosis of cancer cells. | 2002 Jan 10 |
1 |
| 83 |
11857034 | Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL. | 2002 Feb |
3 |
| 84 |
11956588 | Doxorubicin enhances TRAIL-induced apoptosis in prostate cancer. | 2002 May |
7 |
| 85 |
11992538 | Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis. | 2002 Jun 1 |
8 |
| 86 |
12014636 | Chemosensitization of T-47D breast carcinoma cells to TRAIL and Fas receptor-induced killing. | 2002 Mar-Apr |
1 |
| 87 |
12398939 | Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosis. | 2002 Oct |
3 |
| 88 |
12439752 | Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells. | 2002 Nov 14 |
1 |
| 89 |
12496481 | Doxorubicin pretreatment sensitizes prostate cancer cell lines to TRAIL induced apoptosis which correlates with the loss of c-FLIP expression. | 2002 Sep-Oct |
6 |
| 90 |
11245478 | Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis. | 2001 Feb 15 |
1 |
| 91 |
11417478 | In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-kappa B activity. | 2001 Jun |
5 |
| 92 |
11468181 | TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications. | 2001 Aug 1 |
8 |
| 93 |
11472983 | Tumor necrosis factor-related apoptosis-inducing ligand and chemotherapy cooperate to induce apoptosis in mesothelioma cell lines. | 2001 Jul |
2 |
| 94 |
11751478 | Adriamycin sensitizes the adriamycin-resistant 8226/Dox40 human multiple myeloma cells to Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-mediated (TRAIL) apoptosis. | 2001 Dec |
7 |
| 95 |
11772267 | Concepts in the use of TRAIL/Apo2L: an emerging biotherapy for myeloma and other neoplasias. | 2001 Aug |
2 |
| 96 |
12118126 | Enhanced apoptosis of soft tissue sarcoma cells with chemotherapy: A potential new approach using TRAIL. | 2001 Dec |
1 |
| 97 |
10690508 | Molecular determinants of response to TRAIL in killing of normal and cancer cells. | 2000 Feb |
4 |
| 98 |
10933923 | The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER/DR5-dependent colon cancer apoptosis. | 2000 Feb |
1 |
| 99 |
10960439 | Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines. | 2000 Sep |
1 |
| 100 |
11090076 | Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L-induced apoptosis of human acute leukemia cells. | 2000 Dec 1 |
2 |